Introduction
Insulinlike growth factor I (IGF-I),' a polypeptide closely related to pro-insulin, is secreted primarily by the liver in response to growth hormone (GH) (1, 2) . IGF-I is believed to mediate most of the growth-promoting actions of GH (3) . Both in vivo and in vitro secretion of pituitary GH have been shown to be suppressed by various IGF-I (somatomedin C) preparations (4) (5) (6) (7) (8) (9) . We have recently shown that IGF-I suppresses basal GH messenger RNA (mRNA) levels in rat pituitary cells (10) and also inhibits growth hormone-releasing hormone (GHRH)-and triiodothyronine (T3)-induced GH mRNA stimulation (10, 11) .
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1. Abbreviations used in this paper: EGF, epidermal growth factor; FGF, fibroblast growth factor, GH, growth hormone; GHRH, GH-releasing hormone; IGF-I, insulinlike growth factor I; NC, nitrocellulose; PRL, prolactin; T3, triiodothyronine.
This negative feedback of GH secretion appears to be analogous to the regulation of other pituitary trophic hormones by their respective target hormones. For example, glucocorticoids inhibit the transcription of the proopiomelanocortin gene (12) , and thyroid hormone inhibits thyroid-stimulating hormone gene expression (13) . It is unclear whether the suppression of GH gene expression occurs at a transcriptional level, or whether the observed effects of IGF-I could be ascribed to posttranscriptional suppression of GH expression. This study shows that IGF-I directly inhibits the synthesis of new GH mRNA in primary rat pituitary cell cultures.
Methods
Materials. Recombinant human IGF-I (Thr 59) was purchased from Amgen Biologicals, Thousand Oaks, CA. GHRH (human pancreatic GRF-1-44) was purchased from Peninsula Laboratories (Belmont, CA), while epidermal growth factor (EGF) and fibroblast growth factor (FGF) were purchased from Collaborative Research (Lexington, MA). Semisynthetic purified human insulin was kindly provided by Squibb-Novo, (Princeton, NJ).
Transcription assay. 2-mo-old male Sprague-Dawley rats (220-240 g; Simonsen, Gilroy, CA) were decapitated and their anterior pituitary glands were enzymatically dispersed, as previously described (10) . Dispersed pituitary cells were initially plated in serum-containing (2.5% fetal calf serum) medium (HyClone, Logan, UT) and then maintained in serum-free Dulbecco's modified Eagle's medium for 24 h as described previously (10, 14) , except that cultures were in 175-cm2 flasks. After 1-to 24-h treatment of 5-10 X 106 cells with or without added IGF-I, the cells were scraped from the flasks in sterile phosphate-buffered saline and collected by low-speed centrifugation. The cell pellets were homogenized in 0.32 M sucrose, 3 mM CaC12, 2 mM Mg acetate, 0.1 mM EDTA, 10 mM Tris-HCl, pH 8.0, 0.1% Triton X, and 1 mM dithiothreitol (DTT) using 15 strokes of the tight pestle of a Dounce homogenizer (15 (14, 16) . The ethanol precipitable RNA was dried and dissolved in 100 ,l of sterile water. An aliquot (2 Ml) was removed for determining total input cpm. Transcripts containing rGH sequences were quantified by hybridization to nitrocellulose (NC) paper containing immobilized rGH complementary DNA (cDNA) and pBR322 plasmid (each 2 ug) using the dot blot apparatus (Schleicher and Schuell, Inc., Keene, NH). The NC paper, cut into strips, was placed in a polyethylene bag with 1 ml prehybridization buffer consisting of 50% deionized formamide, SX standard saline citrate (SSC), 0.1% SDS, Sx Denhardt's solution, denatured salmon was included in all experiments to determine the efficiency of hybridization and was synthesized as described elsewhere (17) Specificity ofIGF-I effect on GH gene transcription. GHRH has clearly been shown to stimulate transcription of the GH gene (21) ; therefore, the effects of IGF-I were tested with GHRH treatment of the cells. As shown in Fig. 3 A, the twofold stimulation of new GH mRNA synthesis induced by GHRH was blocked by IGF-I (3.25 nM). Other growth factors, including EGF and FGF, did not alter GH transcription (Fig. 3 B) . Relatively high doses of insulin (200 nM) also suppressed the GH gene transcriptional activity (Fig. 3 C) . This may indicate that insulin is acting via the IGF-I receptor, or alternatively, insulin may specifically inhibit GH gene transcription, in these cells, as we have recently shown for GH3 cell GH gene transcription (22) . (10) and GH secretion (4, 5, 8, 9) , and also to occur in vivo after intracerebroventricular insertion (6, 7) . IGF-I did not alter the total incorporation of [32P]GTP into RNA in the nuclear transcription assay. This indicates that IGF-I did not generally suppress the total RNA synthesis in these experiments. This is in agreement with our previous observations that total pituitary RNA levels were not altered in rats bearing GH-secreting tumors with resultant elevated IGF-I levels (25) . These experiments demonstrate for the first time, that the IGF-I (Thr-59) analogue (26) with similar competitive binding and bioactive behavior to purified somatomedin C (27) , a naturally occurring polypeptide, is able to suppress transcription of the pituitary GH gene. Heretofore, the transcriptional regulation of GH has been shown to be primarily stimulatory by T3, hydrocortisone, and GHRH (28) (29) (30) (31) . Although somatostatin inhibits the release of GH, this hypothalamic hormone has not been shown to regulate GH gene expression (32) . Insulin has also been shown to suppress GH secretion, mRNA levels, and GH gene transcription, but the dose response and time course for these observations clearly differed from the effects elicited by IGF-I (10, 14, 22, 33) .
The previously observed inhibition of pituitary GH mRNA levels induced by IGF-I (10) may have been due to other posttranscriptional events, including an increase in GH mRNA degradation, processing, or transport (34) . The half-life of GH mRNA in GH cells has been reported to range from 40 to 56 h (30) , while in other studies a shorter half-life has been reported (31) . We have previously shown that IGF-I inhibits the GH mRNA levels in normal rat pituitary cells after 48 h, and also suppresses GH secretion after only 4 h (10). This would suggest that IGF-I may also act at a posttranscriptional level to inhibit GH secretion. Nevertheless, the data shown here indicate that IGF-I directly and selectively inhibits the synthesis of nascent GH mRNA in normal rat pituitary cells without altering PRL mRNA synthesis.
These observations indicate the presence of a negative feedback loop in the regulation of pituitary GH gene transcription. In addition to GHRH, T3, and hydrocortisone, therefore, IGF-I participates in the balance of GH gene regulation by inhibiting GH gene transcription. This observation may explain the high GH levels seen in starvation and protein-calorie malnutrition where IGF-I levels are suppressed (35) . These findings may also provide the molecular mechanism for the regulation of human GH secretion (9) and GH mRNA levels (36) by IGF-I. The physiologic significance ofthese reciprocal changes remain to be determined. cisco, CA. 
